Extremely Low 90-Day Cardiac Device Infection Rates With TYRX Antibacterial Envelope Use
5/13/2013 8:11:56 AM
More...
|
TYRX Release: Nearly 50% of Patients With Cardiac Device Infections Don’t Survive Beyond Three Years
5/10/2013 12:42:40 PM
More...
|
Health Canada Clears TYRX' New AIGISRx® R
1/31/2013 7:25:51 AM
More...
|
GE Capital Agents $8.5 Million Senior Secured Credit Facility for Medtech Company TYRX
1/29/2013 10:06:19 AM
More...
|
Vanderbilt Study Shows Sharp Decline in Cardiac Device Infections With TYRX® AIGISRx® Antibacterial Envelope
12/19/2012 10:07:41 AM
More...
|
TYRX Release: Vanderbilt Study Shows Sharp Decline in Cardiac Device Infections With TYRX® AIGISRx® Antibacterial Envelope
12/18/2012 9:25:59 AM
More...
|
TYRX Release: Medicare Ruling Concerns Hospital CEOs, but Better Reporting, New Antibiotic Technology Can Lower Cardiac Device Infection Rates
10/11/2012 10:06:16 AM
More...
|
TYRX Receives Health Canada Approval
10/4/2012 6:55:49 AM
More...
|
TYRX Receives New Product Innovation Award
9/14/2012 9:07:45 AM
More...
|
TYRX Release: Over 50% of Hospital CFOs Plan to Adopt New Technology in Response to Medicare Cuts for Cardiac Device Infections
8/20/2012 9:41:22 AM
More...
|
|